These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 23844749)

  • 1. Consumer cost sharing and use of biopharmaceuticals for rheumatoid arthritis.
    Robinson JC
    Am J Manag Care; 2013 Jun; 19(6):e205-13. PubMed ID: 23844749
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of Medicare Part D on access to and cost sharing for specialty biologic medications for beneficiaries with rheumatoid arthritis.
    Polinski JM; Mohr PE; Johnson L
    Arthritis Rheum; 2009 Jun; 61(6):745-54. PubMed ID: 19479704
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Does competition by health maintenance organizations affect the adoption of cost-containment measures by fee-for-service plans?
    Joesch JM; Wickizer TM; Feldstein PJ
    Am J Manag Care; 1998 Jun; 4(6):832-8. PubMed ID: 10181069
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of the effect of a consumer-driven health plan on medical care expenditures and utilization.
    Parente ST; Feldman R; Christianson JB
    Health Serv Res; 2004 Aug; 39(4 Pt 2):1189-210. PubMed ID: 15230920
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Awakening consumer stewardship of health benefits: prevalence and differentiation of new health plan models.
    Rosenthal M; Milstein A
    Health Serv Res; 2004 Aug; 39(4 Pt 2):1055-70. PubMed ID: 15230911
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Coverage for high-cost specialty drugs for rheumatoid arthritis in Medicare Part D.
    Yazdany J; Dudley RA; Chen R; Lin GA; Tseng CW
    Arthritis Rheumatol; 2015 Jun; 67(6):1474-80. PubMed ID: 25900105
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The direct and indirect effects of cost-sharing on the use of preventive services.
    Solanki G; Schauffler HH; Miller LS
    Health Serv Res; 2000 Feb; 34(6):1331-50. PubMed ID: 10654834
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of Cost-Sharing Increases on Continuity of Specialty Drug Use: A Quasi-Experimental Study.
    Li P; Hu T; Yu X; Chahin S; Dahodwala N; Blum M; Pettit AR; Doshi JA
    Health Serv Res; 2018 Aug; 53 Suppl 1(Suppl Suppl 1):2735-2757. PubMed ID: 28736929
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prescription drugs: elderly enrollee reports of financial access, receipt of free samples, and discussion of generic equivalents related to type of coverage.
    Taira DA; Iwane KA; Chung RS
    Am J Manag Care; 2003 Apr; 9(4):305-12. PubMed ID: 12703674
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of cost sharing on prescription drugs used by Medicare beneficiaries.
    Goedken AM; Urmie JM; Farris KB; Doucette WR
    Res Social Adm Pharm; 2010 Jun; 6(2):100-9. PubMed ID: 20511109
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Specialty Tier-Level Cost Sharing and Biologic Agent Use in the Medicare Part D Initial Coverage Period Among Beneficiaries With Rheumatoid Arthritis.
    Doshi JA; Hu T; Li P; Pettit AR; Yu X; Blum M
    Arthritis Care Res (Hoboken); 2016 Nov; 68(11):1624-1630. PubMed ID: 27014854
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effect of incentive-based formularies on prescription-drug utilization and spending.
    Huskamp HA; Deverka PA; Epstein AM; Epstein RS; McGuigan KA; Frank RG
    N Engl J Med; 2003 Dec; 349(23):2224-32. PubMed ID: 14657430
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The impact of increasing patient prescription drug cost sharing on therapeutic classes of drugs received and on the health status of elderly HMO members.
    Johnson RE; Goodman MJ; Hornbrook MC; Eldredge MB
    Health Serv Res; 1997 Apr; 32(1):103-22. PubMed ID: 9108807
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Utilization, patient satisfaction, and cost implications of acupuncture, massage, and naturopathic medicine offered as covered health benefits: a comparison of two delivery models.
    Stewart D; Weeks J; Bent S
    Altern Ther Health Med; 2001; 7(4):66-70. PubMed ID: 11452569
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Health-insurance products and plan options.
    Youkstetter WD
    Am J Hosp Pharm; 1990 Oct; 47(10):2265-9. PubMed ID: 2248267
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effect of insurance type on prescription drug use and expenditures among elderly Medicare beneficiaries.
    Saleh SS; Weller W; Hannan E
    J Health Hum Serv Adm; 2007; 30(1):50-74. PubMed ID: 17557696
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Use and Spending for Biologic Disease-Modifying Antirheumatic Drugs for Rheumatoid Arthritis Among US Medicare Beneficiaries.
    Yazdany J; Tonner C; Schmajuk G
    Arthritis Care Res (Hoboken); 2015 Sep; 67(9):1210-1218. PubMed ID: 25776035
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gatekeeping and patterns of outpatient care post healthcare reform.
    Barnett ML; Song Z; Bitton A; Rose S; Landon BE
    Am J Manag Care; 2018 Oct; 24(10):e312-e318. PubMed ID: 30325192
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differences in prescription drug use in HMO and self-insured health plans.
    Wallack SS; Thomas CP; Martin TC; Ryan A
    Med Care Res Rev; 2007 Feb; 64(1):98-116. PubMed ID: 17213460
    [TBL] [Abstract][Full Text] [Related]  

  • 20. When patients have to pay a share of drug costs: effects on frequency of physician visits, hospital admissions and filling of prescriptions.
    Anis AH; Guh DP; Lacaille D; Marra CA; Rashidi AA; Li X; Esdaile JM
    CMAJ; 2005 Nov; 173(11):1335-40. PubMed ID: 16301701
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.